Literature DB >> 8628875

Prostate carcinoma: MR imaging findings after cryosurgery.

C L Kalbhen1, H Hricak, K Shinohara, M Chen, F Parivar, J Kurhanewicz, D B Vigneron, P R Carroll.   

Abstract

PURPOSE: To determine the morphologic changes in the prostate gland after cryosurgery and to assess the value of magnetic resonance (MR) imaging in detecting residual tumor.
MATERIALS AND METHODS: Twenty-seven patients with prostate carcinoma underwent endorectal MR imaging after cryosurgery. Eighteen patients also underwent MR imaging before cryosurgery. MR findings were correlated with posttreatment clinical data, prostate-specific antigen level, and biopsy results.
RESULTS: Mean prostate volume had decreased by 52% in patients examined 8 weeks or more after cryosurgery. Zonal differentiation was lost in 22 of 27 patients (81%). Areas of intraprostatic necrosis were identified in 14 of 27 patients (52%). A thick capsule enveloped the gland and neurovascular bundles in 24 of 27 patients (89%). Osteonecrosis of the symphysis pubis was seen in six of 27 patients (22%). Positive and negative predictive values for MR assessment of recurrent tumor were 44% and 73%, respectively.
CONCLUSION: Cryosurgery-induced changes in the prostate gland preclude reliable detection of residual prostate carcinoma at MR imaging.

Entities:  

Mesh:

Year:  1996        PMID: 8628875     DOI: 10.1148/radiology.198.3.8628875

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  14 in total

Review 1.  Three-dimensional magnetic resonance spectroscopic imaging of brain and prostate cancer.

Authors:  J Kurhanewicz; D B Vigneron; S J Nelson
Journal:  Neoplasia       Date:  2000 Jan-Apr       Impact factor: 5.715

2.  Reproducibility of image interpretation in MRI of the prostate: application of the sextant framework by two different radiologists.

Authors:  Ullrich Mueller-Lisse; Ulrike Mueller-Lisse; Juergen Scheidler; Gerhardt Klein; Maximilian Reiser
Journal:  Eur Radiol       Date:  2005-04-20       Impact factor: 5.315

3.  Post-processing correction of the endorectal coil reception effects in MR spectroscopic imaging of the prostate.

Authors:  Susan M Noworolski; Galen D Reed; John Kurhanewicz; Daniel B Vigneron
Journal:  J Magn Reson Imaging       Date:  2010-09       Impact factor: 4.813

Review 4.  Roundtable: arguments in support of using multi-parametric prostate MRI protocol.

Authors:  Sirisin Kamsut; Kimberly Reid; Nelly Tan
Journal:  Abdom Radiol (NY)       Date:  2020-12

Review 5.  MR imaging of treated prostate cancer.

Authors:  Hebert Alberto Vargas; Cecilia Wassberg; Oguz Akin; Hedvig Hricak
Journal:  Radiology       Date:  2012-01       Impact factor: 11.105

Review 6.  Monitoring tumour response.

Authors:  J E Husband
Journal:  Eur Radiol       Date:  1996       Impact factor: 5.315

7.  The role of magnetic resonance imaging (MRI) in focal therapy for prostate cancer: recommendations from a consensus panel.

Authors:  Berrend G Muller; Jurgen J Fütterer; Rajan T Gupta; Aaron Katz; Alexander Kirkham; John Kurhanewicz; Judd W Moul; Peter A Pinto; Ardeshir R Rastinehad; Cary Robertson; Jean de la Rosette; Rafael Sanchez-Salas; J Stephen Jones; Osamu Ukimura; Sadhna Verma; Hessel Wijkstra; Michael Marberger
Journal:  BJU Int       Date:  2013-11-13       Impact factor: 5.588

8.  Prostate cryotherapy monitoring using vibroacoustography: preliminary results of an ex vivo study and technical feasibility.

Authors:  Farid G Mitri; Brian J Davis; Azra Alizad; James F Greenleaf; Torrence M Wilson; Lance A Mynderse; Mostafa Fatemi
Journal:  IEEE Trans Biomed Eng       Date:  2008-11       Impact factor: 4.538

Review 9.  Advances in MR spectroscopy of the prostate.

Authors:  John Kurhanewicz; Daniel B Vigneron
Journal:  Magn Reson Imaging Clin N Am       Date:  2008-11       Impact factor: 2.266

Review 10.  Imaging of prostate cancer local recurrences: why and how?

Authors:  Olivier Rouvière; Thierry Vitry; Denis Lyonnet
Journal:  Eur Radiol       Date:  2009-11-17       Impact factor: 5.315

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.